| Followers | 842 |
| Posts | 122795 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Friday, August 30, 2013 12:43:20 PM
[Updated for Form-4 filings through 8/28/13.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 580,503 1,052,000
*G Venkataraman (SVP/R&D) 424,774 229,803
*John Bishop (SVP/Pharma) 99,865 174,530
*Richard Shea (CFO) 149,544 273,650
*Bruce Leicher (Gen Cnsl) 109,360 218,228
*James Roach (CMO) 86,951 270,411
Directors
John Clarke 69,123 179,250
Bruce Downey 0 98,250
Marsha Fanucci 9,000 140,850
Peter Hutt 5,365 184,250
Thomas Koestler 0 65,500
*Bennett Shapiro 7,000 158,450
*Elizabeth Stoner 11,143 104,117
James Sulat 10,000 103,250
======================== ========= =========
All fourteen insiders 1,562,898 3,252,539
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
